{"id":"https://openalex.org/W2089210700","doi":"https://doi.org/10.1016/s0028-3908(97)00038-5","title":"SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist","display_name":"SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist","publication_year":1997,"publication_date":"1997-04-01","ids":{"openalex":"https://openalex.org/W2089210700","doi":"https://doi.org/10.1016/s0028-3908(97)00038-5","mag":"2089210700","pmid":"https://pubmed.ncbi.nlm.nih.gov/9225286"},"language":"en","primary_location":{"id":"doi:10.1016/s0028-3908(97)00038-5","doi":"https://doi.org/10.1016/s0028-3908(97)00038-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0028-3908(97)00038-5","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111548142","display_name":"G.A. Kennett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.A. KENNETT","raw_affiliation_strings":["Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, Harlow, Essex, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, Harlow, Essex, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103815893","display_name":"Martyn D. Wood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.D. WOOD","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"F. BRIGHT","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. BRIGHT","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015740753","display_name":"Brenda K. Trail","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. TRAIL","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110530460","display_name":"G. J. Riley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. RILEY","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051047691","display_name":"Vicky A. Holland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. HOLLAND","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060748668","display_name":"Kim Y. Avenell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K.Y. AVENELL","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083378279","display_name":"Tania O. Stean","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. STEAN","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110078581","display_name":"N. Upton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. UPTON","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033256342","display_name":"Steven M. Bromidge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"S. BROMIDGE","raw_affiliation_strings":["Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111720094","display_name":"Ian T. Forbes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I.T. FORBES","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086423794","display_name":"Arthur M Brown","orcid":"https://orcid.org/0000-0002-8725-3195","observed_orcids":["https://orcid.org/0000-0002-8725-3195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.M. BROWN","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022674193","display_name":"Derek N. Middlemiss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.N. MIDDLEMISS","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083104098","display_name":"Thomas P. Blackburn","orcid":"https://orcid.org/0000-0001-9317-7507","observed_orcids":["https://orcid.org/0000-0001-9317-7507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T.P. BLACKBURN","raw_affiliation_strings":["Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5033256342"],"corresponding_institution_ids":[],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":8.1262,"has_fulltext":false,"cited_by_count":526,"citation_normalized_percentile":{"value":0.98472527,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"36","issue":"4-5","first_page":"609","last_page":"620"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sb-242084","display_name":"SB242084","score":0.9559999704360962},{"id":"https://openalex.org/keywords/5-ht2c-receptor-antagonist","display_name":"5-HT2C receptor antagonist","score":0.9430000185966492},{"id":"https://openalex.org/keywords/selective-serotonin-receptor-antagonists","display_name":"selective serotonin receptor antagonists","score":0.781000018119812},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.8429999947547913},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.9279999732971191},{"id":"https://openalex.org/keywords/social-interaction","display_name":"social interaction","score":0.5350000262260437},{"id":"https://openalex.org/keywords/food-intake-reduction","display_name":"hypophagia","score":0.6940000057220459},{"id":"https://openalex.org/keywords/m-chlorophenylpiperazine","display_name":"m-chlorophenylpiperazine","score":0.9120000004768372},{"id":"https://openalex.org/keywords/seizure-susceptibility","display_name":"seizure susceptibility","score":0.6449999809265137},{"id":"https://openalex.org/keywords/food-consumption","display_name":"dietary intake","score":0.6819999814033508},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.5239999890327454},{"id":"https://openalex.org/keywords/sh-sy5y-cells","display_name":"SH-SY5Y cells","score":0.703000009059906},{"id":"https://openalex.org/keywords/mouse-mutants","display_name":"mouse mutants","score":0.3240000009536743}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8441055417060852},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6378286480903625},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6098189353942871},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.5704759955406189},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5215701460838318},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5193420648574829},{"id":"https://openalex.org/C2780632750","wikidata":"https://www.wikidata.org/wiki/Q18027437","display_name":"5-HT2C receptor","level":5,"score":0.5114237666130066},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.49442100524902344},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.49027207493782043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42965513467788696},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36782318353652954},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17257973551750183},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003220","descriptor_name":"Conflict, Psychological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004597","descriptor_name":"Electroshock","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005247","descriptor_name":"Feeding Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010716","descriptor_name":"Phosphatidylinositols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012919","descriptor_name":"Social Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0028-3908(97)00038-5","doi":"https://doi.org/10.1016/s0028-3908(97)00038-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0028-3908(97)00038-5","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:9225286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9225286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.5899999737739563,"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W129649145","https://openalex.org/W1763330810","https://openalex.org/W1787051283","https://openalex.org/W1936333617","https://openalex.org/W1968303737","https://openalex.org/W1969855549","https://openalex.org/W1981818755","https://openalex.org/W1982931433","https://openalex.org/W1984868484","https://openalex.org/W1987503039","https://openalex.org/W1993000687","https://openalex.org/W1996140740","https://openalex.org/W1998734661","https://openalex.org/W2010914134","https://openalex.org/W2020548744","https://openalex.org/W2022288151","https://openalex.org/W2022404244","https://openalex.org/W2024952531","https://openalex.org/W2025678690","https://openalex.org/W2037997999","https://openalex.org/W2038500073","https://openalex.org/W2038620688","https://openalex.org/W2052451560","https://openalex.org/W2059279128","https://openalex.org/W2061359205","https://openalex.org/W2064455131","https://openalex.org/W2071508479","https://openalex.org/W2074631079","https://openalex.org/W2077466070","https://openalex.org/W2084882106","https://openalex.org/W2085482875","https://openalex.org/W2090409852","https://openalex.org/W2094815197","https://openalex.org/W2095131733","https://openalex.org/W2106719090","https://openalex.org/W2143957256","https://openalex.org/W2151682336","https://openalex.org/W2153853866","https://openalex.org/W2264473966","https://openalex.org/W2331337476","https://openalex.org/W2398650533","https://openalex.org/W2401188729","https://openalex.org/W2504902102","https://openalex.org/W6637881654","https://openalex.org/W6693164902"],"related_works":["https://openalex.org/W2006567701","https://openalex.org/W2006319615","https://openalex.org/W1967367855","https://openalex.org/W2023347084","https://openalex.org/W2025678690","https://openalex.org/W2095131733","https://openalex.org/W2020145519","https://openalex.org/W2021705695","https://openalex.org/W2054287670","https://openalex.org/W2140175678"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}